PI-LAB-2025-055

Gonadorelin, Independent Lab Report

Gonadorelin 2mg · NextGen Peptides

Discrepancy

Independent testing verdict Discrepancy

This product was authentic but did not match its label.

Identity confirmed, but measured purity of 97.3% fell short of the stated ≥99% claim.

Identity verified
Yes

Mass spectrometry confirmed the labelled compound

Measured purity
97.3%

Label claimed ≥99%

Content accuracy
102.5%

2.05mg measured against 2mg claimed

Test recency
Current cycle

Published 12 months ago

Specimen PI-LAB-2025-055 Tested by Redpoint Laboratories 17 samples tested from this company Purity & Testing score 91/100

Full laboratory evidence Findings table, methodology, chain of custody and the original report

Findings

Metric Label claim Measured Assessment
Purity (HPLC) ≥ 99% 97.3% Materially below claim
Identity (MS) Gonadorelin Confirmed Matches label
Content 2 mg 2.05 mg Within 5% of label

Methodology & chain of custody

RP-HPLC purity with electrospray ionisation mass confirmation.

The sample was purchased anonymously through standard retail checkout and shipped to an unaffiliated address, then logged, photographed, and forwarded under chain-of-custody documentation to Redpoint Laboratories. See our full testing methodology.

Lot / batch
L5154-25
Purchased
Analysed
Published
Laboratory
Redpoint Laboratories
Test type
Content verification

Testing notes

Company was notified before publication and given the standard dispute window.

Original laboratory report: PI-LAB-2025-055-report.pdf (document delivery arrives with the production storage backend)

More Tests, NextGen Peptides

PT-141
Purity 98.5% Verified
Retatrutide
Purity 99.7% Verified
Tirzepatide/Cagrilintide Blend
Purity 97.6% Verified

More Tests, Gonadorelin

Gonadorelin Halcyon Biosciences
Purity 98.4% Verified
Gonadorelin NextGen Peptides
Purity 96.9% Verified
Gonadorelin Halcyon Biosciences
Purity 99.5% Verified